The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM statement

9 Apr 2020 07:00

RNS Number : 2729J
Location Sciences Group PLC
09 April 2020
 

Location Sciences Group PLC("Location Sciences" or the "Company")

 

AGM Statement

 

Location Sciences (AIM: LSAI), the leading location data verification company, is holding its Annual General Meeting ("AGM") at 9.00am today at 20 Eastbourne Terrace, Paddington London W2 6LG. Ahead of the formal business of the AGM, Kelvin Harrison, Non-Executive Chairman of Location Sciences, will make the following statement:.

 

"The COVID-19 pandemic is having a significant impact on businesses across the world and Location Sciences, while being a software company, is not immune to these effects. While half of our revenues are fixed monthly fees, and therefore relatively secure, the other half are based on the volume of location advertising.

 

"Location Sciences' existing customer base is largely within the QSR (quick service restaurants), retail and leisure sectors, which have all been significantly impacted by the UK Government's restrictions. Consequently, while Q1 performance was in-line with the Board's expectations, the Directors anticipate Q2 revenues to be lower than previously expected. However, the Company's annual revenues are typically heavily weighted towards Q4, therefore the Directors expect to recover some of those Q2 lost revenues as brands seek to make up lost ground in the latter part of 2020.

 

"Shareholders should take comfort that, as a cloud-based software business, Location Sciences, which operates in four locations globally, has not seen a material impact on its core operations or services. It is well placed to act on the opportunities it sees in the marketplace.

 

"One such opportunity is to use the Company's location technology and considerable knowhow to assist the UK Government in understanding the effects of its policies, as well as to be part of any track and trace COVID-19 solution. The Directors are actively working with the Company's partners, and reaching out directly to the UK Government, to inform its decision making. The ultimate aim is to be part of a technology solution to supress the spread of COVID-19 while allowing some form of normality to return to the economy and to everyday lives. The Directors will keep shareholders updated on any material developments in this regard.

 

"With Q2 revenues likely to be lower than previously expected, the Company has also undertaken certain cost cutting measures. These include putting the Company's marketing and business development budgets on hold until there is greater visibility on when revenues are expected to return to normal levels. There is also considerable effort going into product development, which runs alongside our MRC accreditation process. Consequently, our engineering teams have never been busier. Since the year end, the Company has moved some of its engineering and data science team to the Ukraine, which gives us access to high calibre talent at competitive rates, as well as a degree of flexibility when demand increases for customer deliverables. In combination with the rationalisation programme undertaken in H2 2019, there are now only 16 full time staff serving four global locations. The Directors will monitor the need for more cost cutting depending on how long it takes for revenues to return to previous levels.

 

"Lastly, and on a personal note, while the impact of the COVID-19 pandemic has been felt by businesses globally, the personal impact of those affected is by far the most significant. It is with great sadness that I report that one of our longstanding shareholders passed away from the virus on Monday. All our thoughts are with his family and friends at this time. Please take care and heed the Government's advice; by all pulling in the same direction we will get through this together."

 

For further information please contact: 

 

Location Sciences Group PLC

via Milk and Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, Chief Financial Officer

 

 

 

 

Shore Capital (Nomad and Joint Broker)

 

Tel: +44 (0)20 7408 4090

Tom Griffiths

 

David Coaten

 

 

 

Peterhouse Capital (Joint Broker)

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

 

 

 

Milk & Honey PR

 Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Jessica Ballinger

 

 

The person making this notification on behalf of the Company is David Rae, Chief Financial Officer of the Company.

 

About Location Sciences

Location Sciences is the pre-eminent global location verification provider to the $190 billion digital advertising industry, working in partnership with brands, media agencies and suppliers to reduce ad wastage and improve the effectiveness of location-based advertising campaigns.

The digital advertising marketplace remains unregulated and unmonitored, with an estimated $19 billion wasted on ad fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUWSVRRWUSRAR
Date   Source Headline
16th Jun 20142:05 pmRNSResult of AGM
16th Jun 20147:00 amRNSAGM Statement
12th Jun 20147:00 amRNSPartnership with PrePay Solutions
9th Jun 20147:00 amRNSDirector Appointment
3rd Jun 20147:00 amRNSProxama's TapPoint® used to launch Ubisoft® Game
30th Apr 20147:00 amRNSFinal Results
24th Apr 201412:01 pmRNSNotice of Results
8th Apr 20147:58 amRNSHolding(s) in Company
12th Mar 20147:00 amRNSExclusive partnership with HID Global
24th Feb 20147:00 amRNSLicensing agreement for Latin and South America
20th Feb 20147:00 amRNSLaunch of mobile contactless payment solution
18th Feb 20147:00 amRNSProxama to partner Weve for Mobile Loyalty Service
30th Jan 20147:00 amRNSNFC Solution with Argos
28th Jan 20147:00 amRNSHolding(s) in Company
23rd Jan 20147:00 amRNSPre-Close Trading Statement
6th Jan 20143:33 pmRNSResult of General Meeting
23rd Dec 20137:00 amRNSDirector/PDMR Shareholding
10th Dec 20135:25 pmRNSPosting of the Circular to Shareholders
4th Dec 20137:00 amRNSDirector/PDMR Shareholding
3rd Dec 20137:00 amRNSPlacing
25th Nov 201312:39 pmRNSChange of Adviser
28th Oct 20137:00 amRNSGlobal NFC agreement with CBS Outdoor
8th Oct 20137:00 amRNSAppointment of broker
4th Oct 20137:00 amRNSNFC solution for Isis mobile platform
30th Sep 20137:00 amRNSAgreement with Posterscope
27th Sep 201312:30 pmRNSHalf Yearly Report
6th Sep 20134:17 pmRNSHolding(s) in Company
3rd Sep 20135:29 pmRNSWEBINAR ON M-COMMERCE SECURITY
27th Aug 20132:32 pmRNSHolding(s) in Company
23rd Aug 20137:00 amRNSAdmission to trading on AIM
22nd Aug 201311:54 amRNSResult of GM and Change of Name to Proxama Plc
5th Aug 201312:06 pmRNSSchedule 1 - Longships Plc
26th Jul 20137:00 amRNSResignation of Director
26th Jul 20137:00 amRNSDetails of recommended transaction
12th Jul 20137:00 amRNSHalf Yearly Report
18th Jun 20137:00 amRNSChange of Adviser
3rd Jun 20134:29 pmRNSHolding(s) in Company
3rd Jun 201310:10 amRNSTotal Voting Rights
24th May 201310:48 amRNSResult of AGM
23rd May 20133:24 pmRNSHolding(s) in Company
17th May 20133:38 pmRNSHolding(s) in Company
10th May 20133:03 pmRNSIssue of options
7th May 201311:30 amRNSCompletion of Fundraising and Issue of Equity
24th Apr 20132:51 pmRNSFinal Results
21st Dec 201211:05 amRNSDirector/PDMR Shareholding
18th Dec 201211:00 amRNSIssue of Equity
27th Sep 20121:23 pmRNSHalf Yearly Report
23rd Aug 20121:15 pmRNSCompletion of B Share Scheme
31st Jul 20124:59 pmRNSTotal Voting Rights
27th Jul 201212:00 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.